📰 Ciences News
Page 56 - Ciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.
May 5, 2023
KELOWNA, BC, May 5, 2023 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (the "Company"), a life sciences company focused on mental health and wellness, is pleased
May 5, 2023
DWK Life Sciences ("DWK"), a leading global manufacturer and supplier of laboratory glassware, plasticware, and primary packaging solutions, has completed the acquisition of Assem-Pak Aluseal ("Assem-Pak")
May 4, 2023
BURLINGTON, N.C., May 4, 2023 /PRNewswire/ -- Labcorp , a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live on May 11 at 9:00... | May 4, 2023
May 4, 2023
If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal
May 4, 2023
ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound , today announced that the company will report financial results for the three months ended March 31, 2023 on Monday, May... | May 4, 2023
May 3, 2023
FOSTER CITY, CA / ACCESSWIRE / May 3, 2023 / The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership
May 3, 2023
© Provided by Xinhua BEIJING, May 3 (Xinhua) -- In a laboratory at the Chinese Academy of Agricultural Sciences (CAAS) in northern Beijing, researchers
May 3, 2023
Back to Press releases Lausanne, Switzerland, Nestlé has officially inaugurated the Institute of Agricultural Sciences to help advance sustainable food... | May 3, 2023
May 3, 2023
Swiss biotech Gnubiotics Sciences SA, a pioneering company in glyco-immunology research to develop human therapeutics, is pleased to announce the appointment of two highly respected individuals as senior
May 2, 2023
LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today